Reference
Noseworthy PA, et al. Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation. Journal of the American College of Cardiology 67: 3020-1, No. 25, 28 Jun 2016. Available from: URL: http://doi.org/10.1016/j.jacc.2016.04.026
Rights and permissions
About this article
Cite this article
Bleeding risk lower with oral anticoagulants than warfarin. Reactions Weekly 1609, 5 (2016). https://doi.org/10.1007/s40278-016-19301-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-19301-5